Stay updated with breaking news from Harmonic Discovery. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
— Companies will co-develop inhibitors of a dark kinase target (NEK1) identified for cancer dependency by Turbine’s Simulated Cell™ platform — LONDON & BUDAPEST, Hungary & NEW YORK--(BUSINESS WIRE)--Turbine, a company that is building the world’s first predictive simulation...
/PRNewswire/ -- Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced...
Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced an exclusive lice
Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced an exclusive lice
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!